About this document

Mood Stabilizer Trends in Schizophrenia by Leslie Citrome is a document available to read on EtoBox.

Mood stabilizer use among patients with schizophrenia in New York psychiatric hospitals has steadily increased from 1994 to 2003. By 2003, nearly 60% of patients with schizophrenia were receiving mood stabilizers like lithium, valproate, carbamazepine, and lamotrigine, compared to 36.5% in 1994. Limited evidence from case reports and randomized controlled trials exists to support the use of mood stabilizers for schizophrenia. The reasons for the increasing use may include changing patient populations in sta

Author

Leslie Citrome

Language

EN